Company Filing History:
1 out of 1,975 
1 out of 2 
1 out of 1 Years Active: 2021-2025
Title: The Innovative Mind of Raymond V. Fucini: Pioneering Advances in G-Protein Coupled Receptor Modulation
Introduction: Raymond V. Fucini, based in San Bruno, California, is an accomplished inventor with a remarkable portfolio that includes three patents. His innovative work primarily focuses on the modulation of G-protein coupled receptors, which play a critical role in various physiological processes. Fucini's research has the potential to significantly advance therapeutic approaches for numerous diseases and disorders.
Latest Patents: Fucini's latest patents revolve around chemical entities capable of modulating the glucagon-like peptide-1 receptor (GLP-1R) and the gastric inhibitory polypeptide receptor (GIPR). These compounds, including pharmaceutically acceptable salts, provide valuable therapeutic benefits, such as agonizing or antagonizing the activities of these receptors. The modulation of GLP-1R and GIPR can enhance existing activity levels, paving the way for effective treatment and prevention strategies against various pathologies. Furthermore, his disclosures detail methods of making and utilizing these chemical entities, showcasing the potential for significant advancements in drug development.
Career Highlights: Throughout his career, Fucini has made notable contributions to the field of pharmaceutical innovation. His time at Amgen Inc. and Cannot Therapeutics, Inc. allowed him to collaborate with leading experts and engage in impactful research, strengthening the efficacy of potential treatments that address critical health issues.
Collaborations: Fucini has had the opportunity to work alongside talented professionals such as Daniel A. Erlanson and Shyam Krishnan. These collaborations highlight the importance of teamwork in driving innovation and achieving breakthroughs in the competitive landscape of pharmaceutical research.
Conclusion: Raymond V. Fucini stands out as a visionary inventor dedicated to improving healthcare outcomes through innovative research in G-protein coupled receptor modulation. His patents exemplify the potential for significant advancements in therapeutics, reflecting his commitment to enhancing the quality of life for individuals affected by various diseases and disorders. With a strong foundation built on collaboration and expertise, Fucini's future contributions to the field are eagerly anticipated.